ArticleGene therapy2010

The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host.

Z S Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.